Salzman, Carl

Suicidality and Risk of Suicide—Definition, Drug Safety Concerns, and a Necessary Target for Drug Development: A Consensus Statement

Meyer, R. E., Salzman, C., Youngstrom, E. A., Clayton, P. J., Goodwin, F. K., Mann, J. J., Alphs, L. D., Broich, K., Goodman, W. K., Greden, J. F., et al. (2010) · The Journal of Clinical Psychiatry

Suicide and Self-Harm StudiesBipolar Disorder and Treatment

Cited by 129

Cognitive improvement following benzodiazepine discontinuation in elderly nursing home residents

Salzman, C., Fisher, J., Nobel, K., Glassman, R., Wolfson, A., & Kelley, M. (1992) · International Journal of Geriatric Psychiatry

Pharmaceutical Practices and Patient OutcomesDementia and Cognitive Impairment Research

Cited by 117

Lack of Relationship Between Long-Term Use of Benzodiazepines and Escalation to High Dosages

Soumerai, S. B., Simoni-Wastila, L., Singer, C., Mah, C., Gao, X., Salzman, C., & Ross-Degnan, D. (2003) · Psychiatric Services

Pharmaceutical Practices and Patient OutcomesOpioid Use Disorder Treatment

Cited by 104

Benzodiazepines: it's time to return to the evidence

Silberman, E., Balon, R., Starcevic, V., Shader, R., Cosci, F., Fava, G. A., Nardi, A. E., Salzman, C., & Sonino, N. (2021) · The British Journal of Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesSynthesis and pharmacology of benzodiazepine derivatives

Cited by 54

Marijuana and hostility in a small-group setting

Salzman, C., van der Kolk, B. A., & Shader, R. I. (1976) · American Journal of Psychiatry

Cannabis and Cannabinoid ResearchNeurotransmitter Receptor Influence on Behavior

Cited by 48

Effects of Fluvoxamine and Paroxetine on Sleep Structure in Normal Subjects: A Home-Based Nightcap Evaluation During Drug Administration and Withdrawal

Silvestri, R., Pace-Schott, E. F., Gersh, T., Stickgold, R., Salzman, C., & Hobson, J. A. (2001) · The Journal of Clinical Psychiatry

Sleep and related disordersTreatment of Major Depression

Cited by 40

International Task Force on Benzodiazepines

Balon, R., Chouinard, G., Cosci, F., Dubovsky, S. L., Fava, G. A., Freire, R. C., Greenblatt, D. J., Krystal, J. H., Nardi, A. E., Rickels, K., et al. (2018) · Psychotherapy and Psychosomatics

Pharmaceutical Practices and Patient OutcomesAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 35

Racial Disparities in Access After Regulatory Surveillance of Benzodiazepines

Pearson, S.-A., Soumerai, S., Mah, C., Zhang, F., Simoni-Wastila, L., Salzman, C., Cosler, L. E., Fanning, T., Gallagher, P., & Ross-Degnan, D. (2006) · Archives of Internal Medicine

Opioid Use Disorder TreatmentPharmaceutical Practices and Patient Outcomes

Cited by 34

An 87-year-old woman taking a benzodiazepine

Salzman, C. (1999) · JAMA

Pharmaceutical Practices and Patient OutcomesPoisoning and overdose treatments

Cited by 18

Manual of Clinical Psychopharmacology, 5th ed

Salzman, C. (2006) · The Journal of Clinical Psychiatry

Treatment of Major DepressionSchizophrenia research and treatment

Cited by 5